Ever Source Wealth Advisors, LLC Verona Pharma PLC Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 6,158 shares of VRNA stock, worth $413,324. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,158
Previous 194
3074.23%
Holding current value
$413,324
Previous $5,000
5600.0%
% of portfolio
0.02%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VRNA
# of Institutions
218Shares Held
70.5MCall Options Held
1.4MPut Options Held
299K-
Perceptive Advisors LLC New York, NY6.39MShares$429 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$375 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$227 Million9.42% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$210 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$210 Million2.81% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4.09B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...